3-drug regimens (RHE and RHZ) would result in an initial failure rate of 17% with an additional 10 to 20% of the patients relapsing by the end of their second year-an overall failure rate of 30 to 40%. A 100% conversion rate could probably be achieved by the addition of a fourth drug initially or by prolongation of the therapy period, but both options would still require strict control of drug compliance, probably best accomplished by developing programmes of direct administration of medication.